Teladoc will acquire digital health company Livongo for $18.5 billion. The deal would combine one of the largest telehealth companies with a platform for managing an array of chronic conditions, including diabetes and heart disease.
The question has shifted from whether telehealth will play a substantial role going forward to how virtual care will reinvent our experience, and the role that health systems and physicians will play in that change.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Through the challenges of the Covid-19 pandemic, caring for whole person health is vital for personal wellness and for business.
Livongo saw its membership and revenue double in the first quarter of 2020, leading into the pandemic. The company also landed a large contract with the Government Employee Health Association, a payer that provides insurance to federal employees.
Throughout this public health crisis, we have faced immense challenges and unimaginably sad losses, but we must either learn lessons from it or risk wasting the sacrifices we’ve made.
Recent moves by the Food and Drug Administration have given digital health companies a big boost during the Covid-19 pandemic. The FDA gave Livongo an emergency use authorization to allow its blood glucose monitors to be used in hospitals, and has loosened requirements around the use of digital tools for mental health.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Covid-19 has taken a particularly heavy toll on people with chronic conditions. We must make it easier for people to stay healthy at home by providing them with the information, supplies, and support they need delivered when and where they need it.
Telehealth companies are scaling up their services to meet growing demand from patients during the Covid-19 pandemic. But will more patients continue to use their services in the long term?
At Livongo, we have developed and rolled out a targeted coronavirus response effort to keep our Members healthy, informed, and supported through the duration of this pandemic.
CVS Health added five companies to its platform for third-party solutions for Caremark clients. Its users will have access to Livongo, Hinge Health and three other solutions.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
After going public last year, digital health startup Livongo saw its membership nearly double in 2019. The company saw significant uptake for its diabetes solution, a trend it expects to continue after striking several key partnerships.
Healthcare startups saw smaller amounts of investment after a record-breaking 2018, according to a report from Silicon Valley Bank. Despite the dip in funding, 2019 saw more deals overall, led by increased investment into healthcare technology companies.
Livongo and Dexcom struck a partnership on Monday that would combine Dexcom’s continuous glucose monitors with Livongo’s software. At the StartUp Health Conference, Livongo President Jennifer Schneider said its work with Dexcom would create a new stream of data for both companies.
Another entrant in the increasingly crowded field of diabetes digital health startups, Virta Health raised $93 million in a series C round. The company uses a ketogenic diet and health coaches in conjunction with its software to turn around type 2 diabetes.
Medical device maker Dexcom is partnering with Livongo such that users of Livongo that have diabetes and use Dexcom's continuous glucose monitoring system can sync their data on the Livongo platform.